Abreva and Yervoy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Abreva and Yervoy together.

The phase IV clinical study analyzes what interactions people who take Abreva and Yervoy have. It is created by eHealthMe based on reports of 1 person who takes the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 04, 2022

1 person who takes Abreva and Yervoy together, and has interactions is studied.


What is Abreva?

Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 19,516 Yervoy users for its effectiveness, alternative drugs and more.

Number of Abreva and Yervoy reports submitted per year:

Abreva and Yervoy drug interactions.

Common Abreva and Yervoy drug interactions by gender *:

female:

n/a

male:

  1. Headache
  2. Sinus disorder

Common Abreva and Yervoy drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Headache
  2. Sinus disorder

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Abreva and Yervoy?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Abreva and Yervoy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Abreva side effects:

Browse all side effects of Abreva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Yervoy side effects:

Browse all side effects of Yervoy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Yervoy interactions:

Browse all interactions between Yervoy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on docosanol and ipilimumab (the active ingredients of Abreva and Yervoy, respectively), and Abreva and Yervoy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Abreva and Yervoy.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: